arrow_back Back to App

Biotechnology Innovation Foundation: Accelerating Development and Access to New Products

This act establishes a new foundation aimed at accelerating the commercialization of biotechnology products in the U.S. This is intended to provide citizens with faster access to innovative solutions in medicine, agriculture, and other fields, by fostering collaboration between government, businesses, and academia. The foundation will also educate the public about biotechnology and its applications.
Key points
Establishment of the Foundation for Enabling Biotechnology Innovation to support the development and commercialization of biotech products.
The Foundation will promote public-private partnerships, facilitating collaboration between federal agencies, industry, academia, and non-profit organizations.
Foundation activities will include public education, training programs, and supporting research on market acceptance and regulatory process improvement.
The goal is to accelerate the introduction of innovative biotechnology products to the market, potentially benefiting health, agriculture, and other sectors.
The Foundation will be independent of the government, will not regulate products, and its finances will be transparent and subject to audits.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2696
Sponsor: Sen. Padilla, Alex [D-CA]
Process start date: 2025-09-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Foundation for Enabling Biotechnology Innovation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2696.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-09-03.

What are the main provisions?

Key points include:

  • Establishment of the Foundation for Enabling Biotechnology Innovation to support the development and commercialization of biotech products.
  • The Foundation will promote public-private partnerships, facilitating collaboration between federal agencies, industry, academia, and non-profit organizations.
  • Foundation activities will include public education, training programs, and supporting research on market acceptance and regulatory process improvement.
  • The goal is to accelerate the introduction of innovative biotechnology products to the market, potentially benefiting health, agriculture, and other sectors.
  • The Foundation will be independent of the government, will not regulate products, and its finances will be transparent and subject to audits.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Padilla, Alex [D-CA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Public Investments Economy